Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Top Budesonide Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Budesonide Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Nasal Spray
1.3.3 Inhaler
1.3.4 Pill&Rectal Forms
1.4 Market Segment by Application
1.4.1 Global Budesonide Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Respiratory Disease Treatment
1.4.3 Nose Disease Treatment
1.4.4 Inflammatory Bowel Disease Treatment
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Budesonide Revenue (2015-2026)
2.1.1 Global Budesonide Revenue (2015-2026)
2.1.2 Global Budesonide Sales (2015-2026)
2.2 Budesonide Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Budesonide Sales by Regions (2015-2020)
2.2.2 Global Budesonide Revenue by Regions (2015-2020)
2.3 Global Top Budesonide Regions (Countries) Ranking by Market Size
2.4 Budesonide Industry Trends
2.4.1 Budesonide Market Top Trends
2.4.2 Market Drivers
2.4.3 Budesonide Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Budesonide Players: Views for Future
3 Competitive Landscape by Manufacturers
3.1 Global Top Budesonide Manufacturers by Sales (2015-2020)
3.1.1 Global Budesonide Sales by Manufacturers (2015-2020)
3.1.2 Global Budesonide Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Budesonide Sales in 2019
3.2 Global Top Manufacturers Budesonide by Revenue
3.2.1 Global Budesonide Revenue by Manufacturers (2015-2020)
3.2.2 Global Budesonide Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Budesonide Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Budesonide as of 2019)
3.4 Global Budesonide Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Budesonide Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Budesonide Market
3.7 Key Manufacturers Budesonide Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Budesonide Historic Market Review by Type (2015-2020)
4.1.2 Global Budesonide Sales Market Share by Type (2015-2020)
4.1.3 Global Budesonide Revenue Market Share by Type (2015-2020)
4.1.4 Budesonide Price by Type (2015-2020)
4.1 Global Budesonide Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Budesonide Sales Forecast by Type (2021-2026)
4.2.3 Global Budesonide Revenue Forecast by Type (2021-2026)
4.2.4 Budesonide Price Forecast by Type (2021-2026)
5 Global Budesonide Market Size by Application
5.1 Global Budesonide Historic Market Review by Application (2015-2020)
5.1.2 Global Budesonide Sales Market Share by Application (2015-2020)
5.1.3 Global Budesonide Revenue Market Share by Application (2015-2020)
5.1.4 Budesonide Price by Application (2015-2020)
5.2 Global Budesonide Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Budesonide Sales Forecast by Application (2021-2026)
5.2.3 Global Budesonide Revenue Forecast by Application (2021-2026)
5.2.4 Budesonide Price Forecast by Application (2021-2026)
6 North America
6.1 North America Budesonide Breakdown Data by Company
6.2 North America Budesonide Breakdown Data by Type
6.3 North America Budesonide Breakdown Data by Application
6.4 North America Budesonide Breakdown Data by Countries
6.4.1 North America Budesonide Sales by Countries
6.4.2 North America Budesonide Revenue by Countries
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Budesonide Breakdown Data by Company
7.2 Europe Budesonide Breakdown Data by Type
7.3 Europe Budesonide Breakdown Data by Application
7.4 Europe Budesonide Breakdown Data by Countries
7.4.1 Europe Budesonide Sales by Countries
7.4.2 Europe Budesonide Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Budesonide Breakdown Data by Company
8.2 Asia Pacific Budesonide Breakdown Data by Type
8.3 Asia Pacific Budesonide Breakdown Data by Application
8.4 Asia Pacific Budesonide Breakdown Data by Regions
8.4.1 Asia Pacific Budesonide Sales by Regions
8.4.2 Asia Pacific Budesonide Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Budesonide Breakdown Data by Company
9.2 Latin America Budesonide Breakdown Data by Type
9.3 Latin America Budesonide Breakdown Data by Application
9.4 Latin America Budesonide Breakdown Data by Countries
9.4.1 Latin America Budesonide Sales by Countries
9.4.2 Latin America Budesonide Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Budesonide Breakdown Data by Type
10.2 Middle East and Africa Budesonide Breakdown Data by Application
10.3 Middle East and Africa Budesonide Breakdown Data by Countries
10.3.1 Middle East and Africa Budesonide Sales by Countries
10.3.2 Middle East and Africa Budesonide Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Business Overview and Total Revenue (2019 VS 2018)
11.1.3 AstraZeneca Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 AstraZeneca Budesonide Products and Services
11.1.5 AstraZeneca SWOT Analysis
11.1.6 AstraZeneca Recent Developments
11.2 Cosmo Pharmaceuticals
11.2.1 Cosmo Pharmaceuticals Corporation Information
11.2.2 Cosmo Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Cosmo Pharmaceuticals Budesonide Products and Services
11.2.5 Cosmo Pharmaceuticals SWOT Analysis
11.2.6 Cosmo Pharmaceuticals Recent Developments
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Teva Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Teva Budesonide Products and Services
11.3.5 Teva SWOT Analysis
11.3.6 Teva Recent Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Mylan Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Mylan Budesonide Products and Services
11.4.5 Mylan SWOT Analysis
11.4.6 Mylan Recent Developments
11.5 Sandoz
11.5.1 Sandoz Corporation Information
11.5.2 Sandoz Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Sandoz Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Sandoz Budesonide Products and Services
11.5.5 Sandoz SWOT Analysis
11.5.6 Sandoz Recent Developments
11.6 Dr. Falk Pharma
11.6.1 Dr. Falk Pharma Corporation Information
11.6.2 Dr. Falk Pharma Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Dr. Falk Pharma Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Dr. Falk Pharma Budesonide Products and Services
11.6.5 Dr. Falk Pharma SWOT Analysis
11.6.6 Dr. Falk Pharma Recent Developments
11.7 Chiesi Farmaceutici S.p.A
11.7.1 Chiesi Farmaceutici S.p.A Corporation Information
11.7.2 Chiesi Farmaceutici S.p.A Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Chiesi Farmaceutici S.p.A Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Chiesi Farmaceutici S.p.A Budesonide Products and Services
11.7.5 Chiesi Farmaceutici S.p.A SWOT Analysis
11.7.6 Chiesi Farmaceutici S.p.A Recent Developments
11.8 Orion Corporation
11.8.1 Orion Corporation Corporation Information
11.8.2 Orion Corporation Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Orion Corporation Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Orion Corporation Budesonide Products and Services
11.8.5 Orion Corporation SWOT Analysis
11.8.6 Orion Corporation Recent Developments
11.9 Cipla
11.9.1 Cipla Corporation Information
11.9.2 Cipla Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Cipla Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Cipla Budesonide Products and Services
11.9.5 Cipla SWOT Analysis
11.9.6 Cipla Recent Developments
11.10 Synmosa Biopharma Corporation
11.10.1 Synmosa Biopharma Corporation Corporation Information
11.10.2 Synmosa Biopharma Corporation Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Synmosa Biopharma Corporation Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Synmosa Biopharma Corporation Budesonide Products and Services
11.10.5 Synmosa Biopharma Corporation SWOT Analysis
11.10.6 Synmosa Biopharma Corporation Recent Developments
11.11 Lunan Better Pharmaceutical
11.11.1 Lunan Better Pharmaceutical Corporation Information
11.11.2 Lunan Better Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Lunan Better Pharmaceutical Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Lunan Better Pharmaceutical Budesonide Products and Services
11.11.5 Lunan Better Pharmaceutical SWOT Analysis
11.11.6 Lunan Better Pharmaceutical Recent Developments
11.12 Shanghai Sine Promod Pharmaceutical
11.12.1 Shanghai Sine Promod Pharmaceutical Corporation Information
11.12.2 Shanghai Sine Promod Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Shanghai Sine Promod Pharmaceutical Budesonide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Shanghai Sine Promod Pharmaceutical Budesonide Products and Services
11.12.5 Shanghai Sine Promod Pharmaceutical SWOT Analysis
11.12.6 Shanghai Sine Promod Pharmaceutical Recent Developments
12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Budesonide Sales Channels
12.2.2 Budesonide Distributors
12.3 Budesonide Customers
13 Estimates and Projections by Regions (2021-2026)
13.1 Global Budesonide Sales Forecast (2021-2026)
13.1.1 Global Budesonide Sales Forecast by Regions (2021-2026)
13.1.2 Global Budesonide Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Budesonide Sales Forecast (2021-2026)
13.2.2 North America Budesonide Revenue Forecast (2021-2026)
13.2.3 North America Budesonide Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Budesonide Sales Forecast (2021-2026)
13.3.2 Europe Budesonide Revenue Forecast (2021-2026)
13.3.3 Europe Budesonide Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Budesonide Sales Forecast (2021-2026)
13.4.2 Asia Pacific Budesonide Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Budesonide Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Budesonide Sales Forecast (2021-2026)
13.5.2 Latin America Budesonide Revenue Forecast (2021-2026)
13.5.3 Latin America Budesonide Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Budesonide Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Budesonide Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Budesonide Size Forecast by County (2021-2026)
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
【掲載企業】
AstraZeneca、Cosmo Pharmaceuticals、Teva、Mylan、Sandoz、Dr. Falk Pharma、Chiesi Farmaceutici S.p.A、Orion Corporation、Cipla、Synmosa Biopharma Corporation、Lunan Better Pharmaceutical、Shanghai Sine Promod Pharmaceutical
【免責事項】
https://www.globalresearch.jp/disclaimer